AzTrials
AzTrials

BurnsNCT00136097

Study on the Infection Risk of Long Dwell Period Catheters in High Risk Intensive Care Unit (ICU) Patients

A study testing Placement of a silver impregnated central venous catheter in people with Burns, run by University Hospital, Ghent at 1 site in Belgium.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This is an evaluation of the use of silver impregnated catheters in burn patients to reduce catheter colonisation compared to the standard central venous catheter without antiseptic activity. Read more about this study

Who is it for?
Any age
Conditions the study is for
Burns
What is being tested?
Placement of a silver impregnated central venous catheter
Type of treatment
Medical device
How many people
142 participants
Where
1 siteBelgium
Study dates
Aug 2005to Jun 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Burn patient
  • Placement of a new trilumen central venous catheter

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • University Hospital Ghent

    Ghent, 9000

Other trials in Belgium

About this study

Official title: Study on the Infection Risk of Long Dwell Period Catheters in High Risk ICU Patients

This is an evaluation of the use of silver impregnated catheters in burn patients to reduce catheter colonisation compared to the standard central venous catheter without antiseptic activity.

Conditions
Burns
Being tested
Placement of a silver impregnated central venous catheter
Keywords
colonisation of the catheter
Medical subject headings
Burns

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Placement of a silver impregnated central venous catheterDevice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of colonisation of the central venous catheter at the moment of removal

Secondary outcomes (1)
  1. Incidence of a catheter related blood stream infection during the presence of the catheter

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2005 (estimated)
  2. Study startAug 2005
  3. Study completionJun 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Double blind
Enrolment
142 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00136097
Sponsor's protocol ID
2004/266
Status last verified
Dec 2007
First submitted
25 Aug 2005
Last updated
28 Dec 2007
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Placement of a silver impregnated central venous catheter in people with Burns, run by University Hospital, Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Dec 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early. Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of colonisation of the central venous catheter at the moment of removal. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in